Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 91
Filter
1.
Hell J Nucl Med ; 25(1): 83-87, 2022.
Article in English | MEDLINE | ID: mdl-35388805

ABSTRACT

Prostate cancer (PCa) is one of the most common malignancies and cause of cancer death in men. Prostate-specific antigen (PSA) is the most used biomarker in the detection of early PCa. Lately, scientists have been using prostate-specific membrane antigen (PSMA), a glycol-protein that is over-expressed in PCa cells in positron emission tomography/ computed tomography (PET/CT) scans to detect PCa. Gallium-68-PSMA radiotracers, such as 68Ga-PSMA-11, 68Ga-PSMA-617 and 68Ga-PSMA I&T, were firstly introduced in 2011 and fluorine-18-PSMA based radiotracers followed with 18F-PSMA-1007,N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]- 4-18F-fluorobenzyl-L-cysteine(18F-DCFBC) and 2-(3-(1-carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl)-ureido)- pentanedioic acid (18F-DCFPyL), also known as PYLARIFY, being the most used and showed superior results compared to conventional imaging techniques. Differences depending on half-life, clearance and normal organ uptake are being detected through research to determine which of the radiotracers, is the most suitable for each patient. Two of them, 68Ga-PSMA-11 and PLYRIFY, have already been approved by the Food and Drug Administration (FDA). The future of hybrid imaging for PCa is very promising if we consider the advantages of PSMA radiotracers compared to non-PSMA radioligands.


Subject(s)
Positron Emission Tomography Computed Tomography , Prostatic Neoplasms , Gallium Isotopes , Gallium Radioisotopes , Humans , Male , Positron Emission Tomography Computed Tomography/methods , Prostate , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/pathology , Radiopharmaceuticals
2.
Brain Topogr ; 34(5): 632-650, 2021 09.
Article in English | MEDLINE | ID: mdl-34152513

ABSTRACT

Simultaneous EEG-fMRI can contribute to identify the epileptogenic zone (EZ) in focal epilepsies. However, fMRI maps related to Interictal Epileptiform Discharges (IED) commonly show multiple regions of signal change rather than focal ones. Dynamic causal modeling (DCM) can estimate effective connectivity, i.e. the causal effects exerted by one brain region over another, based on fMRI data. Here, we employed DCM on fMRI data in 10 focal epilepsy patients with multiple IED-related regions of BOLD signal change, to test whether this approach can help the localization process of EZ. For each subject, a family of competing deterministic, plausible DCM models were constructed using IED as autonomous input at each node, one at time. The DCM findings were compared to the presurgical evaluation results and classified as: "Concordant" if the node identified by DCM matches the presumed focus, "Discordant" if the node is distant from the presumed focus, or "Inconclusive" (no statistically significant result). Furthermore, patients who subsequently underwent intracranial EEG recordings or surgery were considered as having an independent validation of DCM results. The effective connectivity focus identified using DCM was Concordant in 7 patients, Discordant in two cases and Inconclusive in one. In four of the 6 patients operated, the DCM findings were validated. Notably, the two Discordant and Invalidated results were found in patients with poor surgical outcome. Our findings provide preliminary evidence to support the applicability of DCM on fMRI data to investigate the epileptic networks in focal epilepsy and, particularly, to identify the EZ in complex cases.


Subject(s)
Epilepsy , Magnetic Resonance Imaging , Brain/diagnostic imaging , Brain/surgery , Brain Mapping , Electroencephalography , Epilepsy/diagnostic imaging , Epilepsy/surgery , Humans , Pilot Projects
3.
Respir Res ; 20(1): 134, 2019 Jul 02.
Article in English | MEDLINE | ID: mdl-31266508

ABSTRACT

BACKGROUND: Non-invasive delivery of nebulized surfactant has been a neonatology long-pursued goal. Nevertheless, the clinical efficacy of nebulized surfactant remains inconclusive, in part, due to the great technical challenges of depositing nebulized drugs in the lungs of preterm infants. The aim of this study was to investigate the feasibility of delivering nebulized surfactant (poractant alfa) in vitro and in vivo with an adapted, neonate-tailored aerosol delivery strategy. METHODS: Particle size distribution of undiluted poractant alfa aerosols generated by a customized eFlow-Neos nebulizer system was determined by laser diffraction. The theoretical nebulized surfactant lung dose was estimated in vitro in a clinical setting replica including a neonatal continuous positive airway pressure (CPAP) circuit, a cast of the upper airways of a preterm neonate, and a breath simulator programmed with the tidal breathing pattern of an infant with mild respiratory distress syndrome (RDS). A dose-response study with nebulized surfactant covering the 100-600 mg/kg nominal dose-range was conducted in RDS-modelling, lung-lavaged spontaneously-breathing rabbits managed with nasal CPAP. The effects of nebulized poractant alfa on arterial gas exchange and lung mechanics were assessed. Exogenous alveolar disaturated-phosphatidylcholine (DSPC) in the lungs was measured as a proxy of surfactant deposition efficacy. RESULTS: Laser diffraction studies demonstrated suitable aerosol characteristics for inhalation (mass median diameter, MMD = 3 µm). The mean surfactant lung dose determined in vitro was 13.7% ± 4.0 of the 200 mg/kg nominal dose. Nebulized surfactant delivered to spontaneously-breathing rabbits during nasal CPAP significantly improved arterial oxygenation compared to animals receiving CPAP only. Particularly, the groups of animals treated with 200 mg/kg and 400 mg/kg of nebulized poractant alfa achieved an equivalent pulmonary response in terms of oxygenation and lung mechanics as the group of animals treated with instilled surfactant (200 mg/kg). CONCLUSIONS: The customized eFlow-Neos vibrating-membrane nebulizer system efficiently generated respirable aerosols of undiluted poractant alfa. Nebulized surfactant delivered at doses of 200 mg/kg and 400 mg/kg elicited a pulmonary response equivalent to that observed after treatment with an intratracheal surfactant bolus of 200 mg/kg. This bench-characterized nebulized surfactant delivery strategy is now under evaluation in Phase II clinical trial (EUDRACT No.:2016-004547-36).


Subject(s)
Biological Products/administration & dosage , Drug Delivery Systems/methods , Models, Biological , Nebulizers and Vaporizers , Phospholipids/administration & dosage , Pulmonary Surfactants/administration & dosage , Animals , Biological Products/metabolism , Humans , Infant, Newborn , Lung/drug effects , Lung/metabolism , Male , Particle Size , Phospholipids/metabolism , Pulmonary Surfactants/metabolism , Rabbits
4.
Sci Rep ; 7(1): 10277, 2017 08 31.
Article in English | MEDLINE | ID: mdl-28860611

ABSTRACT

Solid organ transplantation (SOT) outcomes have continued to improve, although long-term use of immunosuppressants can lead to complications such as diabetes, compromising post-transplant outcomes. In this study, we have characterized the intestinal microbiome (IM) composition at the metagenomic level in the context of hyperglycemia induced by immunosuppressants. Sprague-Dawley rats were subjected to doses of tacrolimus and sirolimus that reliably induce hyperglycemia and an insulin-resistant state. Subsequent exposure to probiotics resulted in reversal of hyperglycemia. 16S rRNA and metagenomic sequencing of stool were done to identify the bacterial genes and pathways enriched in immunosuppression. Bacterial diversity was significantly decreased in sirolimus-treated rats, with 9 taxa significantly less present in both immunosuppression groups: Roseburia, Oscillospira, Mollicutes, Rothia, Micrococcaceae, Actinomycetales and Staphylococcus. Following probiotics, these changes were reversed to baseline. At the metagenomic level, the balance of metabolism was shifted towards the catabolic side with an increase of genes involved in sucrose degradation, similar to diabetes. Conversely, the control rats had greater abundance of anabolic processes and genes involved in starch degradation. Immunosuppression leads to a more catabolic microbial profile, which may influence development of diabetes after SOT. Modulation of the microbiome with probiotics may help in minimizing adverse long-term effects of immunosuppression.


Subject(s)
Gastrointestinal Microbiome/immunology , Immunosuppression Therapy/adverse effects , Metagenome , Metagenomics , Animals , Computational Biology/methods , Diabetes Mellitus/etiology , Gene Ontology , Humans , Hyperglycemia/etiology , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Insulin Resistance , Male , Metagenomics/methods , RNA, Ribosomal, 16S , Rats , Sirolimus/adverse effects , Sirolimus/therapeutic use , Systems Biology/methods , Tacrolimus/adverse effects , Tacrolimus/therapeutic use , Transplantation/adverse effects
5.
Monaldi Arch Chest Dis ; 77(2): 67-75, 2012 Jun.
Article in English | MEDLINE | ID: mdl-23193843

ABSTRACT

BACKGROUND: Pulmonary Rehabilitation ("Rehabilitation") can improve both lung function and quality of life in patients suffering from chronic obstructive pulmonary disease (COPD) even if only a very small proportion of patients have access to Rehabilitation. Supplementation of Essential Amino Acids (EAAs) might allow COPD patients to achieve some typical Rehabilitation outcomes such as a better physical performance and an improved health status. METHODS: 88 COPD out-patients (GOLD class 3-4) with a body mass index (BMI) < 23 Kg/m2 were randomised to receive EAAs (n = 44) or placebo (n = 44) for twelve weeks. Primary outcome measures were changes in both physical activities in daily life (measured by Sense Wear Armband in terms of mean steps walked in one week) and in quality of life (measured by the St George's Respiratory Questionnaire, SGRQ). RESULTS: After 12 weeks, the physical performance was significantly increased vs baseline only in patients who received EAAs (1140.33 +/- 524.69 and 638.68 +/- 662.1 steps/day, respectively; p = 0.02), being also the comparison vs the placebo group highly significant (p = 0.003). Similarly, the SGRQ score improved significantly only in EAA patients (69.35 +/- 9.51 vs baseline 72.04 +/- 8.62; p < 0.01), and changes were significantly different from those measured in the placebo group (p < 0.001). Furthermore, when compared to those who received placebo, EAAs patients significantly increased their fat-free mass (p = 0.04), muscle strength (p < 0.01), saturation of oxygen (p = 0.05), serum albumin (p < 0.001), and also ameliorated their original cognitive dysfunction (p = 0.02). CONCLUSIONS: Oral supplementation with EAAs contribute to improve the daily-life performance in domiciliary severe COPD patients who can not enter any Rehabilitation programme, together with their quality of life; nutritional and cognitive status, and muscle strength.


Subject(s)
Amino Acids, Essential/administration & dosage , Dietary Supplements , Exercise Tolerance/physiology , Outpatients , Pulmonary Disease, Chronic Obstructive/rehabilitation , Adult , Aged , Body Composition , Double-Blind Method , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/physiopathology , Quality of Life , Surveys and Questionnaires
6.
Br J Dermatol ; 167(4): 926-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22564212

ABSTRACT

BACKGROUND: Recent evidence indicates that subclinical infection by Chlamydophila psittaci occurs in a significant percentage of patients with chronic inflammatory polyarthritis, including psoriatic arthritis. OBJECTIVE: To assess the prevalence of Chlamydiae infection in a large cohort of well-characterized patients with psoriasis. METHODS: The presence of a subclinical C. psittaci infection was investigated in 64 patients with psoriasis, including 12 patients with psoriatic arthritis. Two hundred and twenty-five healthy controls were also investigated. The presence of infection was assessed in peripheral blood mononuclear cells using several polymerase chain reaction protocols, targeting different regions of the bacterial genome. The DNA of other species (Chlamydophila pneumoniae and Chlamydia trachomatis) was also investigated. RESULTS: Chlamydophila psittaci infection was observed in a significantly higher percentage of patients with psoriasis (11/64, 17%) compared with healthy controls (1/225, 0.4%) (odds ratio 46.49, 95% confidence interval 5.87-368.03; P < 0.0001). No differences in age, sex or disease duration were noticed between positive and negative patients, but the majority of the positive patients were on immunomodulatory treatments. CONCLUSION: Chlamydophila psittaci may be an infectious trigger possibly involved in the pathogenesis of psoriasis.


Subject(s)
Chlamydophila psittaci/isolation & purification , DNA, Bacterial/genetics , Psittacosis/microbiology , Psoriasis/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Chlamydophila psittaci/genetics , Cohort Studies , Female , Humans , Italy , Male , Middle Aged , Polymerase Chain Reaction , Young Adult
7.
Br J Cancer ; 106(5): 966-9, 2012 Feb 28.
Article in English | MEDLINE | ID: mdl-22274411

ABSTRACT

BACKGROUND: Ocular adnexal marginal zone B-cell lymphoma (OAMZL) has been associated with Chlamydophila psittaci, an infection that may be transmitted by carrier animals. However, it is still unclear whether exposure to animals affects the risk of OAMZL in comparison with other lymphoma histotypes. We therefore investigated the role of professional and/or domestic exposures to animals in the occurrence of OAMZL, as compared with other types of lymphoma. METHODS: A hospital-based case-control study was carried out on 43 consecutive OAMZL patients (cases) and 87 consecutive patients with nodal non-Hodgkin's lymphomas (NHLs; controls). Multiple logistic regression (MLR) odds ratios (ORs), and 95% confidence intervals (CIs) were used to estimate the association between exposures to animals and OAMZL risk. RESULTS: A higher proportion of cases reported a lifetime exposure to household animals (79.1% vs 64.4% among controls), with a non-statistical significant MLR-OR of 2.18 (95% CI: 0.85-5.62). The OAMZL cases more frequently reported a history of occupation in breeding and/or slaughtering than controls (34.9% vs 6.9%), with an overall increased risk of 7.69 (95%CI: 2.65-22.34). CONCLUSION: These results indicate that, compared with nodal NHLs, the risk of OAMZL is markedly increased by contact with animals, particularly by occupational exposures.


Subject(s)
Animals, Domestic , Environmental Exposure/adverse effects , Eye Neoplasms/epidemiology , Lymphoma, B-Cell, Marginal Zone/epidemiology , Pets , Adult , Aged , Aged, 80 and over , Animals , Case-Control Studies , Chlamydophila psittaci , Female , Humans , Lymphoma, Non-Hodgkin/epidemiology , Male , Middle Aged , Occupational Exposure/adverse effects , Risk Factors
9.
Int J Immunopathol Pharmacol ; 25(4): 1063-74, 2012.
Article in English | MEDLINE | ID: mdl-23298496

ABSTRACT

Metabolic syndrome (MetS) is a set of metabolic alterations including high levels of low-density lipoprotein (LDL), which increase the risk of cardiomyopathy often leading to surgery. Despite inducing myopathy, statins are widely used to lower LDL. Cardiopulmonary bypass (Cpb) causes oxidative stress and metabolic injury, altering mitochondrial expression (Grp75) and endoplasmic reticulum (Grp78) chaperones, apoptotic enzymes (Bcl2 family) and increasing cardiomyocyte lipid/lipofuscin storage. We believe that cardiomyocytes from patients with MetS may be more sensitive to surgical stress, in particular after simvastatin therapy (MetS+Stat). The study group included ten patients with MetS, ten patients with Mets+Stat and ten healthy subjects. Myocardial biopsies were obtained both before and after-Cpb. Grp75, Grp78, Bax, Bcl2, lipids, lipofuscin and fibrosis were evaluated by immuno/histochemistry. MetS cardiomyocytes had higher Grp75, Bax, fibrosis and lipofuscin. MetS+Stat had lower Grp75 and higher Grp78 expressions, high Bax, fewer fibrosis and higher lipofuscin content. Cpb did not vary the fibrosis and lipids/lipofuscin content, although it influenced the chaperones and Bax expression in all groups. These changes were more profound in patients with MetS and even more so in patients with MetS+Stat. The results suggest that MetS and MetS+Stat cardiomyocytes were more highly stressed after-Cpb. Interestingly, simvastatin caused high stress even before-Cpb.


Subject(s)
Cardiopulmonary Bypass , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Metabolic Syndrome/metabolism , Myocardial Reperfusion Injury/etiology , Myocytes, Cardiac/metabolism , Simvastatin/adverse effects , Stress, Physiological , Aged , Endoplasmic Reticulum Chaperone BiP , Endoplasmic Reticulum Stress , HSP70 Heat-Shock Proteins/analysis , Humans , Male , Membrane Proteins/analysis , Metabolic Syndrome/pathology , Middle Aged , Myocytes, Cardiac/pathology , Proto-Oncogene Proteins c-bcl-2/analysis , bcl-2-Associated X Protein/analysis
10.
Leukemia ; 26(4): 814-21, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22024723

ABSTRACT

Evidence from certain geographical areas links lymphomas of the ocular adnexa marginal zone B-cell lymphomas (OAMZL) with Chlamydophila psittaci (Cp) infection, suggesting that lymphoma development is dependent upon chronic stimulation by persistent infections. Notwithstanding that, the actual immunopathogenetical mechanisms have not yet been elucidated. As in other B-cell lymphomas, insight into this issue, especially with regard to potential selecting ligands, could be provided by analysis of the immunoglobulin (IG) receptors of the malignant clones. To this end, we studied the molecular features of IGs in 44 patients with OAMZL (40% Cp-positive), identifying features suggestive of a pathogenic mechanism of autoreactivity. Herein, we show that lymphoma cells express a distinctive IG repertoire, with electropositive antigen (Ag)-binding sites, reminiscent of autoantibodies (auto-Abs) recognizing DNA. Additionally, five (11%) cases of OAMZL expressed IGs homologous with autoreactive Abs or IGs of patients with chronic lymphocytic leukemia, a disease known for the expression of autoreactive IGs by neoplastic cells. In contrast, no similarity with known anti-Chlamydophila Abs was found. Taken together, these results strongly indicate that OAMZL may originate from B cells selected for their capability to bind Ags and, in particular, auto-Ags. In OAMZL associated with Cp infection, the pathogen likely acts indirectly on the malignant B cells, promoting the development of an inflammatory milieu, where auto-Ags could be exposed and presented, driving proliferation and expansion of self-reactive B cells.


Subject(s)
Autoantigens/immunology , Eye Neoplasms/immunology , Genes, Immunoglobulin , Lymphoma, B-Cell, Marginal Zone/immunology , Adult , Aged , Aged, 80 and over , Cluster Analysis , Complementarity Determining Regions , Eye Neoplasms/etiology , Female , Humans , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Lymphocyte Activation , Lymphoma, B-Cell, Marginal Zone/etiology , Male , Middle Aged , Psittacosis/complications
11.
Int J Immunopathol Pharmacol ; 24(3): 611-9, 2011.
Article in English | MEDLINE | ID: mdl-21978693

ABSTRACT

The liver sustains the greatest damage from ethanol (EtOH) abuse. EtOH and its metabolites impair hepatocyte metabolism, causing intracellular accumulation of proteins and lipids and increasing radical oxygen species production. These processes are toxic to the mitochondrial respiratory chain and to mitochondrial DNA. We have recently shown that supplementating the diet of rodents with an essential amino acid-enriched mixture (EAAem) significantly increases mitochondrial mass and number in cardiac and skeletal muscles and improves mitochondrial function in aged animals. Thus, in this study we sought to test whether EAAem supplementation could reduce EtOH-induced liver damage. Groups of adult male Wistar rats were fed a standard diet and water ad libitum (the control group), drinking water with 20 percent EtOH (the EtOH group), or drinking water with 20 percent EtOH and EAAem supplementation (1.5 g/kg/day) (the EtOH+EAAem group) for 2 months. The blood EtOH concentration was measured, and markers for fat (Oil-Red-O), mitochondria (Grp75, Cyt-c-ox), endoplasmic reticulum (Grp78), and inflammation (Heme Oxigenase 1, iNOS, and peroxisomes) were analyzed in the liver of animals in the various experimental groups. EAAem supplementation in EtOH-drinking rats ameliorated EtOH-induced changes in liver structure by limiting steatosis, recruiting more mitochondria and peroxisomes mainly to perivenous hepatocytes, stimulating or restoring antioxidant markers, limiting the expression of inflammatory processes, and reducing ER stress. Taken together, these results suggest that EAAem supplementation may represent a promising strategy to prevent and treat EtOH-induced liver damage.


Subject(s)
Amino Acids, Essential/therapeutic use , Dietary Supplements , Hepatitis, Alcoholic/pathology , Hepatitis, Alcoholic/prevention & control , Liver/pathology , Alcohol Drinking , Animals , Azo Compounds , Body Weight/drug effects , Catalase/metabolism , Central Nervous System Depressants/blood , Coloring Agents , Electron Transport Complex IV/metabolism , Endoplasmic Reticulum Chaperone BiP , Ethanol/blood , Fatty Liver/chemically induced , Fatty Liver/metabolism , Histocytochemistry , Immunohistochemistry , Inflammation/genetics , Inflammation/pathology , Male , Organ Size/drug effects , Rats , Rats, Wistar
12.
Transfus Clin Biol ; 17(3): 151-64, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20655788

ABSTRACT

Since its discovery in the 17th century, the red blood cell, recognized in time as the critical cell component for survival, has been the focus of much attention. Its unique role in gas exchange (oxygen/CO(2) transport) and its distinct characteristics (absence of nucleus; biconcave cell shape) together with an - in essence - unlimited supply lead to extensive targeted biochemical, molecular and structural studies. A quick PubMed query with the word "erythrocyte" results in 198 013 scientific articles of which 162 are red blood cell proteomics studies, indicating that this new technique has been only recently applied to the red blood cell and related fields. Standard and comparative proteomics have been widely used to study different blood components. A growing body of proteomics literature has since developed, which deals with the characterization of red blood cells in health and disease. The possibility offered by proteomics to obtain a global snapshot of the whole red blood cell protein make-up, has provided unique insights to many fields including transfusion medicine, anaemia studies, intra-red blood cell parasite biology and translational research. While the contribution of proteomics is beyond doubt, a full red blood cell understanding will ultimately require, in addition to proteomics, lipidomics, glycomics, interactomics and study of post-translational modifications. In this review we will briefly discuss the methodology and limitations of proteomics, the contribution it made to the understanding of the erythrocyte and the advances in red blood cell-related fields brought about by comparative proteomics.


Subject(s)
Erythrocytes/metabolism , Proteomics , Amino Acid Sequence , Anemia/blood , Anemia/genetics , Anemia/metabolism , Blood Proteins/chemistry , Blood Proteins/genetics , Blood Proteins/isolation & purification , Blood Proteins/metabolism , Chromatography, High Pressure Liquid , Cytoskeleton/metabolism , Erythrocyte Membrane/chemistry , Erythrocyte Membrane/metabolism , Humans , Mass Spectrometry , Molecular Sequence Data , Organelles/metabolism , Protein Processing, Post-Translational , Sequence Alignment , Sequence Homology, Amino Acid
13.
Nature ; 455(7214): 799-803, 2008 Oct 09.
Article in English | MEDLINE | ID: mdl-18843368

ABSTRACT

Plasmodium knowlesi is an intracellular malaria parasite whose natural vertebrate host is Macaca fascicularis (the 'kra' monkey); however, it is now increasingly recognized as a significant cause of human malaria, particularly in southeast Asia. Plasmodium knowlesi was the first malaria parasite species in which antigenic variation was demonstrated, and it has a close phylogenetic relationship to Plasmodium vivax, the second most important species of human malaria parasite (reviewed in ref. 4). Despite their relatedness, there are important phenotypic differences between them, such as host blood cell preference, absence of a dormant liver stage or 'hypnozoite' in P. knowlesi, and length of the asexual cycle (reviewed in ref. 4). Here we present an analysis of the P. knowlesi (H strain, Pk1(A+) clone) nuclear genome sequence. This is the first monkey malaria parasite genome to be described, and it provides an opportunity for comparison with the recently completed P. vivax genome and other sequenced Plasmodium genomes. In contrast to other Plasmodium genomes, putative variant antigen families are dispersed throughout the genome and are associated with intrachromosomal telomere repeats. One of these families, the KIRs, contains sequences that collectively match over one-half of the host CD99 extracellular domain, which may represent an unusual form of molecular mimicry.


Subject(s)
Genome, Protozoan/genetics , Genomics , Macaca mulatta/parasitology , Malaria/parasitology , Plasmodium knowlesi/genetics , Amino Acid Sequence , Animals , Antigens, CD/chemistry , Antigens, CD/genetics , Chromosomes/genetics , Conserved Sequence , Genes, Protozoan/genetics , Humans , Molecular Sequence Data , Plasmodium knowlesi/classification , Plasmodium knowlesi/physiology , Protein Structure, Tertiary , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Sequence Analysis, DNA , Telomere/genetics
15.
Minerva Cardioangiol ; 54(2): 257-63, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16778757

ABSTRACT

AIM: Coronary artery bypass graft (CABG) surgery, nowadays, is increasingly performed in patients who are older and have more comorbidities than subjects operated on a decade ago. In this study, we investigated metabolic and hemodynamic features of elderly patients with single vessel coronary artery disease (CAD), undergoing beating heart coronary artery bypass graft (BHCABG) surgery. METHODS: Twenty-five elderly patients, ages 73-78 years, with isolated left anterior descending artery (LAD) disease, were enrolled and compared to a younger similar group of 25 patients, mean age 48+/-1.2 years. A single vessel left internal mammary artery (LIMA) to LAD BHCABG was performed in all patients. Duration of temporary LAD occlusion was 9.8+/-0.5 min in the elderly group, and 10+/-0.4 min in the younger group. Myocardial arterial-venous differences in glucose, lactate, and creatine phosphokinase (CPK) were performed at different time points: preoperatively in the operating room (T0); at the end of the grafting procedure (T1); and before closing the chest (T2). Left ventricular stroke work index (LVSWI), as an indicator of global function of left ventricle, were recorded at T0, T1, T2, 6 (T3) and 48 (T4) hours postoperatively. RESULTS: Preoperative glucose extraction, observed in both groups, did not augment during and after surgery. In addition, neither lactate nor CPK were released in the coronary sinus during temporary LAD occlusion and following reperfusion in either group. Similarly, no significant changes in LVSWI were observed intra- and perioperatively between the two groups. CONCLUSIONS: Cardiac metabolism, hemodynamic parameters and global left ventricular function were not affected in either group by brief LAD occlusion during BHCABG, suggesting that BHCABG is a well-tolerated surgical approach, which can be safely attempted in patients of any age.


Subject(s)
Coronary Artery Bypass , Coronary Artery Disease/metabolism , Coronary Artery Disease/physiopathology , Hemodynamics , Age Factors , Aged , Coronary Artery Disease/surgery , Female , Humans , Male
16.
J Chemother ; 16(6): 582-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15700851

ABSTRACT

We have updated the results of an adjuvant chemotherapy study of 106 patients with osteosarcoma of the extremities published 17 years ago, treated by surgery followed by adjuvant chemotherapy with vincristine (VCR), methotrexate (MTX) and doxorubicin (ADM), between 1980-1983, and followed-up for at least 20 years (20-23 years). In comparison with the results reported 17 years ago with a median follow-up of 38 months (range: 27-66), this updated study showed 24 more deaths, 9 more relapses and 3 second malignancies. Consequently, event-free survival (EFS) and overall survival (OS) are significantly lower compared to the previous study with a 3-year follow up (EFS 38% vs 53%; OS 43.8% vs 67%). We conclude that osteosarcoma patients treated with chemotherapy are at risk of late adverse events. Protracted medical follow-up and long-term updated results are useful to identify, at an early stage, late relapses and late treatment-related complications.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Osteosarcoma/drug therapy , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Chemotherapy, Adjuvant , Child , Disease-Free Survival , Doxorubicin/administration & dosage , Female , Follow-Up Studies , Humans , Male , Methotrexate/administration & dosage , Middle Aged , Morbidity , Osteosarcoma/surgery , Risk Factors , Vincristine/administration & dosage
17.
J Endocrinol Invest ; 26(1): RC1-4, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12602525

ABSTRACT

Recent studies have shown that growth hormone (GH) deficiency may deteriorate post-ischemic myocardial reperfusion damage. Furthermore, GH has been reported to be a promising therapeutic option in the treatment of chronic myocardial dysfunction. However, the exact mechanisms of action of GH on the cardiovascular system, particularly in the acute setting, are still unclear. The aim of our study consisted of monitoring the acute effects of GH infusion on isolated blood-perfused rabbit heart according to dose-response pattern and during ischemic conditions to test its anti-ischemic property. Seven blood-donors perfused isolated hearts were used as experimental model. The mechanical and metabolic data of the isolated organs were continuously monitored. Under aerobic conditions, dose-response curves were initially tested after intracoronary infusion of GH at increasing dosages (1, 2, 3 mg/l). After a stabilization period, the effects of GH infusion (5 mg/kg) administered 30 minutes prior to acute global myocardial ischemia (30 minutes) were also investigated. At the doses tested, GH did not induce any changes either in the developed or in the diastolic pressures of the isolated organ. However, transient reduction of the coronary perfusion pressure was observed at the dosage of 3 mg/l. During the ischemia/reperfusion study, at the dosages used in this study, GH did not modify either the degree of stunning in the early reperfusion or the recovery of the developed pressure at the end of reperfusion. In addition, GH did not prevent either the increase of diastolic pressure during ischemia or the release of lactate and CPK during reperfusion. Tissue content of high-energy phosphates was also not changed by GH infusion. In our experimental model, acute GH infusion did not reduce the ischemic/reperfusion damage of the myocardium. However, GH transiently induced coronary vasodilation without modifying the myocardial contractility. Acute effects of GH appear, therefore, to predominantly relate to vascular dilation suggesting that the effects on myocardial contractility may require long-lasting intake being likely linked to enhancement of specific protein synthesis or gene expression of cardiac myocytes.


Subject(s)
Coronary Vessels/drug effects , Energy Metabolism , Growth Hormone/administration & dosage , Heart/physiopathology , Myocardial Ischemia/physiopathology , Myocardial Reperfusion Injury/physiopathology , Myocardium/metabolism , Animals , Blood , Blood Pressure , Diastole , Dose-Response Relationship, Drug , Heart/drug effects , In Vitro Techniques , Infusions, Intravenous , Male , Myocardial Stunning/physiopathology , Perfusion , Rabbits
18.
Circulation ; 106(12): 1556-62, 2002 Sep 17.
Article in English | MEDLINE | ID: mdl-12234964

ABSTRACT

BACKGROUND: Urocortin is a novel cardioprotective agent that can protect cardiac myocytes from the damaging effects of ischemia/reperfusion both in culture and in the intact heart and is effective when given at reperfusion. METHODS AND RESULTS: We have analyzed global changes in gene expression in cardiac myocytes after urocortin treatment using gene chip technology. We report that urocortin specifically induces enhanced expression of the Kir 6.1 cardiac potassium channel subunit. On the basis of this finding, we showed that the cardioprotective effect of urocortin both in isolated cardiac cells and in the intact heart is specifically blocked by both generalized and mitochondrial-specific K(ATP) channel blockers, whereas the cardioprotective effect of cardiotrophin-1 is unaffected. Conversely, inhibiting the Kir 6.1 channel subunit greatly enhances cardiac cell death after ischemia. CONCLUSIONS: This is, to our knowledge, the first report of the altered expression of a K(ATP) channel subunit induced by a cardioprotective agent and demonstrates that K(ATP) channel opening is essential for the effect of this novel cardioprotective agent.


Subject(s)
Cardiotonic Agents/pharmacology , Corticotropin-Releasing Hormone/pharmacology , Myocardium/metabolism , Potassium Channels, Inwardly Rectifying/biosynthesis , Potassium Channels, Inwardly Rectifying/physiology , Adenosine Triphosphate/metabolism , Animals , Cell Death , Cell Hypoxia , Cells, Cultured , Cytokines/pharmacology , Gene Expression Profiling , Myocardial Reperfusion Injury/metabolism , Myocardium/cytology , Oligonucleotide Array Sequence Analysis , Potassium Channels, Inwardly Rectifying/genetics , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Transcriptional Activation , Urocortins
19.
Cardiovasc Res ; 53(2): 279-85, 2002 Feb 01.
Article in English | MEDLINE | ID: mdl-11827675

ABSTRACT

BACKGROUND: The acceptance rate of non-mother English tongue authors is generally a lot lower than for native English tongue authors. Obviously the scientific quality of an article is the principal reason for publication. However, is editorial rejection purely on scientific grounds? English mother tongue writers publish more than non mother-tongue writers--so are editors discriminating linguistically? We therefore decided to survey language errors in manuscripts submitted for publication to Cardiovascular Research (CVR). METHOD: We surveyed language errors in 120 medical articles which had been submitted for publication in 1999 and 2000. The language "error" categories were divided into three principal groups: grammatical, structural and lexical which were then further sub-divided into key areas. The articles were corrected without any knowledge of the author's nationality or the corrections made by other language researchers. After an initial correction, a sample of the papers were cross-checked to verify reliability. RESULTS: The control groups of US and UK authors had an almost identical acceptance rate and overall "error" rate indicating that the language categories were objective categories also for the other nationalities. Although there was not a direct relationship between the acceptance rate and the amount of language errors, there was a clear indication that badly written articles correlated with a high rejection rate. The US/UK acceptance rate of 30.4% was higher than for all the other countries. The lowest acceptance rate of 9% (Italian) also had the highest error rate. DISCUSSION: Many factors could influence the rejection of an article. However, we found clear indications that carelessly written articles could often have either a direct or subliminal influence on whether a paper was accepted or rejected. On equal scientific merit, a badly written article will have less chance of being accepted. This is even if the editor involved in rejecting a paper does not necessarily identify language problems as a motive for rejection. A more detailed look at the types and categories of language errors is needed. Furthermore we suggest the introduction of standardised guidelines in scientific writing.


Subject(s)
Cardiology , Manuscripts as Topic , Peer Review, Research , Humans , Periodicals as Topic
20.
Ital Heart J Suppl ; 2(7): 754-60, 2001 Jul.
Article in Italian | MEDLINE | ID: mdl-11508293

ABSTRACT

The implementation of a quality management system (QMS) in the health-care world is nowadays mandatory. This is a specific request not only of local laws but also of the World Health Organization which recently said that "By the year 2000, there should be structures and processes in all member States to ensure a continuous improvement in the quality of health care". In addition, we are bombarded by demands from patients, physicians, employers and the administration. However a QMS is something new for the medical doctor. We think that the first step to divulge the culture of quality in our field is to have a good knowledge of the specific terminology used in the QMS. This glossary explains the meaning of more than 80 terms related to the QMS.


Subject(s)
Quality Control , Total Quality Management
SELECTION OF CITATIONS
SEARCH DETAIL
...